All Stories

  1. Novel role of extracellular matrix protein 1 (ECM1) in cardiac aging and myocardial infarction
  2. Saxagliptin but Not Sitagliptin Inhibits CaMKII and PKC via DPP9 Inhibition in Cardiomyocytes
  3. Reply
  4. A novel LMNA nonsense mutation causes two distinct phenotypes of cardiomyopathy with high risk of sudden cardiac death in a large five-generation family
  5. Elevated Cardiac Troponin T in Patients With Skeletal Myopathies
  6. The Anti-Cancer Multikinase Inhibitor Sorafenib Impairs Cardiac Contractility by Reducing Phospholamban Phosphorylation and Sarcoplasmic Calcium Transients
  7. Desmin Phosphorylation Triggers Preamyloid Oligomers Formation and Myocyte Dysfunction in Acquired Heart Failure
  8. Impaired aspirin-mediated platelet function inhibition in resuscitated patients with acute myocardial infarction treated with therapeutic hypothermia: a prospective, observational, non-randomized single-centre study
  9. Unfolding Cardiac Amyloidosis – From Pathophysiology to Cure
  10. Dipeptidyl peptidase-4 independent cardiac dysfunction links saxagliptin to heart failure
  11. ST2 predicts survival in patients undergoing transcatheter aortic valve implantation
  12. Nonmyocyte ERK1/2 signaling contributes to load-induced cardiomyopathy in Marfan mice
  13. Istaroxime, a potential anticancer drug in prostate cancer, exerts beneficial functional effects in healthy and diseased human myocardium
  14. A New Murine Model of Chronic Kidney Disease-Mineral and Bone Disorder
  15. Typical STEMI: or not? Embolic left anterior descending artery occlusion, fulminant pulmonary embolism, and in-transit thrombus in a patent foramen ovale
  16. Old dog, new tricks: novel cardiac targets and stress regulation by protein kinase G
  17. Profilin modulates sarcomeric organization and mediates cardiomyocyte hypertrophy
  18. Bidirectional cross-regulation between ErbB2 and β-adrenergic signalling pathways
  19. Dual Labeling Biotin Switch Assay to Reduce Bias Derived From Different Cysteine SubpopulationsNovelty and Significance
  20. Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease
  21. Response to Letter from Villa-Abrille et al
  22. Precardiac deletion of Numb and Numblike reveals renewal of cardiac progenitors
  23. Cardiomyocyte-Specific Transforming Growth Factor   Suppression Blocks Neutrophil Infiltration, Augments Multiple Cytoprotective Cascades, and Reduces Early Mortality After Myocardial Infarction
  24. Combined TRPC3 and TRPC6 blockade by selective small-molecule or genetic deletion inhibits pathological cardiac hypertrophy
  25. Hyperactive Adverse Mechanical Stress Responses in Dystrophic Heart Are Coupled to Transient Receptor Potential Canonical 6 and Blocked by cGMP-Protein Kinase G Modulation
  26. HNO Enhances SERCA2a Activity and Cardiomyocyte Function by Promoting Redox-Dependent Phospholamban Oligomerization
  27. Bile acids induce arrhythmias in human atrial myocardium—implications for altered serum bile acid composition in patients with atrial fibrillation
  28. A Swinging Pacemaker Lead Promoting Endocarditis and Severe Tricuspid Regurgitation
  29. Sunitinib causes dose-dependent negative functional effects on myocardium and cardiomyocytes
  30. Cardiac Fibrosis in Human Transplanted Hearts Is Mainly Driven by Cells of Intracardiac Origin
  31. Dependence of β3-adrenergic signaling on the adipokine leptin in cardiac myocytes
  32. Glucose-transporter–mediated positive inotropic effects in human myocardium of diabetic and nondiabetic patients
  33. Esophageal ulceration mimicking malignancy in a patient with severe kyphoscoliosis
  34. Functional effects of glucose transporters in human ventricular myocardium